Get the Stockscreener App
7.49
8.10%
-0.53
Prenetics Global Limited stock is traded at $7.49, with a volume of 82,816.
It is down -8.10% in the last 24 hours and up +37.76% over the past month.
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.
See More
Previous Close:
$8.02
Open:
$7.63
24h Volume:
82,816
Relative Volume:
3.55
Market Cap:
$107.01M
Revenue:
$291.44M
Net Income/Loss:
$-44.17M
P/E Ratio:
-1.7833
EPS:
-4.2
Net Cash Flow:
-
1W Performance:
-11.47%
1M Performance:
+37.76%
6M Performance:
+24.07%
1Y Performance:
+22.83%
1-Day Range:
$7.01
$8.50
1-Week Range:
$7.01
$8.99
52-Week Range:
$3.0947
$11.99
Prenetics Global Limited Stock (PRE) Company Profile
Name
Prenetics Global Limited
Sector
Industry
Phone
-
Address
-
Compare PRE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRE
Prenetics Global Limited
|
7.25 | 107.01M | 291.44M | -44.17M | 0 | -4.20 |
|
TMO
Thermo Fisher Scientific Inc
|
407.99 | 150.38B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
202.56 | 137.52B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
524.11 | 42.00B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
118.38 | 32.37B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
158.71 | 25.50B | 15.50B | 1.33B | 2.16B | 7.34 |
Prenetics Global Limited Stock (PRE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-18-23 | Initiated | Cantor Fitzgerald | Overweight |
Prenetics Global Limited Stock (PRE) Latest News
Prenetics Global reports Q1 2025 financials By Investing.com - Investing.com Nigeria
Prenetics Global (NASDAQ:PRE) Issues Quarterly Earnings Results - MarketBeat
Prenetics Global reports Q1 2025 financials - Investing.com
Prenetics Reports Strong Q1 2025 Results and Raises Revenue Outlook - TipRanks
Prenetics reports Q1 EPS (80c) vs ($1.31) last year - TipRanks
Prenetics Announces First Quarter 2025 Financial Results, - GlobeNewswire
(PRE) On The My Stocks Page - news.stocktradersdaily.com
When (PRE) Moves Investors should Listen - news.stocktradersdaily.com
Prenetics Global Announces Board Member Departure - TipRanks
Prenetics Global shares spike on significant revenue developments - Mugglehead Magazine
Where are the Opportunities in (PRE) - news.stocktradersdaily.com
Prenetics Global (NASDAQ:PRE) Shares Down 2.6% – Should You Sell? - Defense World
Prenetics Global Limited's (NASDAQ:PRE) P/S Is Still On The Mark Following 50% Share Price Bounce - simplywall.st
Prenetics Global Full Year 2024 Earnings: Misses Expectations - simplywall.st
PREPrenetics Ltd Latest Stock News & Market Updates - Stock Titan
(PRE) Technical Data - news.stocktradersdaily.com
IM8 Vibrante Miami: Fueling Wellness and Innovation with a Star-Studded Event - markets.businessinsider.com
Prenetics says IM8 hosted Vibrante Miami event - TipRanks
What You Can Learn From Prenetics Global Limited's (NASDAQ:PRE) P/S After Its 27% Share Price Crash - simplywall.st
Prenetics’ IM8 Health Expands Scientific Advisory Board, - GlobeNewswire
Prenetics’ IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements Market - Marketscreener.com
Prenetics to Participate in the 37th Annual ROTH Conference - GlobeNewswire
Prenetics to Participate in the 37th Annual ROTH Conference -March 11, 2025 at 08:31 am EDT - Marketscreener.com
Prenetics Executives Reveal Growth Strategy at ROTH Conference Longevity Panel - StockTitan
FY2024 EPS Forecast for Prenetics Global Reduced by Analyst - Defense World
Short Interest in Prenetics Global Limited (NASDAQ:PRE) Grows By 22.1% - Defense World
Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance - GlobeNewswire
Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance | - Digital More
Prenetics Reports Strong 2024 Results and Optimistic 2025 Outlook - TipRanks
Financial Contrast: Telesis Bio (NASDAQ:TBIO) and Prenetics Global (NASDAQ:PRE) - Defense World
Comparing Prenetics Global (NASDAQ:PRE) & PositiveID (OTCMKTS:PSID) - Armenian Reporter
Prenetics Global Limited (NASDAQ:PRE) Short Interest Down 24.7% in January - MarketBeat
Prenetics Global (NASDAQ:PRE) and Cytek Biosciences (NASDAQ:CTKB) Head to Head Analysis - Defense World
Prenetics Expands into Web3 with Blockchain Identity Partnership - CoinTrust
Prenetics, Humanity Protocol partner for DNA ID - Tech in Asia
Nasdaq-Listed Prenetics Announces Genomics-Based - GlobeNewswire
Nasdaq-Listed Prenetics Enters Crypto Space with Humanity Protocol Partnership - Coinspeaker
Prenetics Partners with Humanity Protocol to Enhance Blockchain-Based Identity Verification and Invests in Digital Assets - Nasdaq
Nasdaq-Listed Prenetics Announces Genomics-Based Partnership with Humanity Protocol and Launches Crypto Strategic Reserve - Marketscreener.com
Prenetics DNA Testing Giant Enters Web3: Teams Up With $1.1B Humanity Protocol, Backs Bitcoin - StockTitan
FY2025 Earnings Forecast for PRE Issued By Cantor Fitzgerald - Defense World
Trend Tracker for (PRE) - Stock Traders Daily
Prenetics Unveils IM8 to U.S. Consumers with Co-Founding Partner David Beckham - GlobeNewswire
Prenetics Global (NASDAQ:PRE) Receives "Overweight" Rating from Cantor Fitzgerald - MarketBeat
Prenetics’ IM8 Achieves Prestigious NSF Certified for Sport® for Daily Ultimate Essentials - GlobeNewswire
Prenetics Global Limited Stock (PRE) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
0.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):